Maternal PPARγ protects nursing neonates by suppressing the production of inflammatory milk
Yihong Wan, Alan Saghatelian, Ling-Wa Chong et al. · Genes & Development · 2007
Lactation is a highly demanding lipid synthesis and transport process that is crucial for the development of newborn mammals. While PPAR gamma is known to promote adipogenesis and lipogenesis in adipose tissue, its role in the lactating mammary gland is unexplored. Here, we report that a targeted deletion of PPAR gamma in mice results in the production of "toxic milk" containing elevated levels of inflammatory lipids. Surprisingly, ingestion of this "toxic milk" causes inflammation, alopecia, and growth retardation in the nursing neonates. Genomic profiling reveals that PPAR gamma deficiency leads to increased expression of lipid oxidation enzymes in the lactating mammary gland. Consistently, metabolomic profiling detects increased levels of oxidized free fatty acids in the pups nursed by PPAR gamma-deficient mothers. Therefore, maternal PPAR gamma is pivotal for maintaining the quality of milk and protecting the nursing newborns by suppressing the production of inflammatory lipids in the lactating mammary gland.
Cited by 104 works. doi:10.1101/gad.1567207 Open-access PDF
Authors
References
- Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor
- An Antidiabetic Thiazolidinedione Is a High Affinity Ligand for Peroxisome Proliferator-activated Receptor γ (PPARγ)
- 15-Deoxy-Δ12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ
- The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
- PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
- XCMS: Processing Mass Spectrometry Data for Metabolite Profiling Using Nonlinear Peak Alignment, Matching, and Identification
- PPARγ Promotes Monocyte/Macrophage Differentiation and Uptake of Oxidized LDL
- Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ
- Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ
- TLR4 links innate immunity and fatty acid–induced insulin resistance